Versatope Therapeutics, Inc.

Versatope Therapeutics is a clinical-stage biotechnology company that develops vaccines and cancer therapeutics using engineered extracellular nano-vesicles derived from probiotic cells. The company's platform technology produces Recombinant Extracellular Transport Vesicles (RET-Vs) that can display multiple viral variants on a single vesicle to provide cross-strain immunity against infectious diseases such as influenza and malaria, and deliver therapeutic RNA to cancer cells.